Dentsply Sirona

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XRAY and other ETFs, options, and stocks.

About XRAY

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. 

CEO
Daniel T. Scavilla
CEODaniel T. Scavilla
Employees
14,000
Employees14,000
Headquarters
Charlotte, North Carolina
HeadquartersCharlotte, North Carolina
Founded
1899
Founded1899
Employees
14,000
Employees14,000

XRAY Key Statistics

Market cap
1.89B
Market cap1.89B
Price-Earnings ratio
-15.58
Price-Earnings ratio-15.58
Dividend yield
1.69%
Dividend yield1.69%
Average volume
5.26M
Average volume5.26M
High today
$9.72
High today$9.72
Low today
$8.14
Low today$8.14
Open price
$8.42
Open price$8.42
Volume
10.28M
Volume10.28M
52 Week high
$14.76
52 Week high$14.76
52 Week low
$8.14
52 Week low$8.14

Stock Snapshot

Dentsply Sirona(XRAY) stock is priced at $9.45, giving the company a market capitalization of 1.89B. It carries a P/E multiple of -15.58 and pays a dividend yield of 1.69%.

During the trading session on 2026-11-09, Dentsply Sirona(XRAY) shares reached a daily high of $9.72 and a low of $8.14. At a current price of $9.45, the stock is +16.2% higher than the low and still -2.7% under the high.

Trading activity shows a volume of 10.28M, compared to an average daily volume of 5.26M.

The stock's 52-week range extends from a low of $8.14 to a high of $14.76.

The stock's 52-week range extends from a low of $8.14 to a high of $14.76.

XRAY News

Simply Wall St 2d
DENTSPLY SIRONA Stock May Be Undervalued As Fiduciary Duty Probe Starts

has had a tough share price run in recent years, so the live question now is whether the current US$9.46 level still makes sense when you line it up against the...

DENTSPLY SIRONA Stock May Be Undervalued As Fiduciary Duty Probe Starts
Zacks 3d
Dentsply Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended September 2026, Dentsply International (XRAY Quick QuoteXRAY - Free Report) reported revenue of $836 million, down 7.5% over the sam...

Dentsply Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks 3d
Dentsply International Q3 Earnings and Revenues Miss Estimates

Dentsply International (XRAY Quick QuoteXRAY - Free Report) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $...

Dentsply International Q3 Earnings and Revenues Miss Estimates

Analyst ratings

68%

of 19 ratings
Buy
26.3%
Hold
68.4%
Sell
5.3%

More XRAY News

Simply Wall St 4d
Dentsply Sirona Stock Faces Fiduciary Breach Investigation Questions

DENTSPLY SIRONA has faced an investigation into potential breaches of fiduciary duty by officers and directors, raising questions over governance and the reliab...

Dentsply Sirona Stock Faces Fiduciary Breach Investigation Questions
Simply Wall St 6d
DENTSPLY SIRONA Climbed, But What Is Behind The Fresh Attention?

DENTSPLY SIRONA stock response to fresh analyst commentary DENTSPLY SIRONA (XRAY) drew attention after new analyst commentary revisited its position as a major...

DENTSPLY SIRONA Climbed, But What Is Behind The Fresh Attention?

People also own

Based on the portfolios of people who own XRAY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.